SMX Public Limited Company has filed a prospectus on July 1, 2024, under Rule 424(b)(3) for the potential future issuance of up to 15,000,000 Ordinary Shares. A Stock Purchase Agreement (SPA) was entered with Generating Alpha, Ltd. on April 19, 2024, which could see Alpha investing up to $30,000,000 in SMX's Ordinary Shares. The shares may be issued after three months from the prospectus date, with sales controlled by SMX and subject to market conditions. The proceeds are intended for working capital and general corporate purposes, with a portion potentially used to repay indebtedness to Alpha. The SPA will terminate after 36 months or once Alpha has purchased the maximum share value. The company, listed on The Nasdaq Capital Market under the symbol 'SMX,' is considered...Show More

SMX Public Limited Company has filed a prospectus on July 1, 2024, under Rule 424(b)(3) for the potential future issuance of up to 15,000,000 Ordinary Shares. A Stock Purchase Agreement (SPA) was entered with Generating Alpha, Ltd. on April 19, 2024, which could see Alpha investing up to $30,000,000 in SMX's Ordinary Shares. The shares may be issued after three months from the prospectus date, with sales controlled by SMX and subject to market conditions. The proceeds are intended for working capital and general corporate purposes, with a portion potentially used to repay indebtedness to Alpha. The SPA will terminate after 36 months or once Alpha has purchased the maximum share value. The company, listed on The Nasdaq Capital Market under the symbol 'SMX,' is considered an 'emerging growth company' and a 'foreign private issuer,' qualifying for reduced disclosure requirements. Investors are cautioned about the inherent risks in investing in the securities, which have not been approved or disapproved by the SEC. Recent company developments include amendments to the SPA, the termination of the CFO, a partnership with Brink’s, share issuances to debtholders, and a securities purchase agreement with Alpha for additional funding.